Showing results (11-20 of 322) with videos related to
Sort By:
Pageof 33
Internal and Emergency Medicine|October 1, 2009
Insights into the pathogenesis and management of thrombosis in polycythemia vera and essential thrombocythemiaAlessandro M VannucchiHematology. American Society of Hematology. Education Program|December 14, 2011
Management of myelofibrosisAlessandro M VannucchiHaematologica|November 26, 2016
From leeches to personalized medicine: evolving concepts in the management of polycythemia veraAlessandro M VannucchiCurrent Opinion in Oncology|September 1, 2010
Advances in understanding and management of polycythemia veraAlessandro M Vannucchi, Paola GuglielmelliTherapeutic Advances in Hematology|April 23, 2013
Ruxolitinib: a potent and selective Janus kinase 1 and 2 inhibitor in patients with myelofibrosis. An update for cliniciansClaire Harrison, Alessandro M VannucchiHematology. American Society of Hematology. Education Program|December 10, 2017
What are the current treatment approaches for patients with polycythemia vera and essential thrombocythemia?Alessandro M Vannucchi, Paola GuglielmelliExpert Opinion on Drug Safety|December 17, 2020
The safety of JAK kinase inhibitors for the treatment of myelofibrosisGiacomo Coltro, Alessandro M VannucchiBlood Reviews|June 18, 2020
Current management strategies for polycythemia vera and essential thrombocythemiaPaola Guglielmelli, Alessandro M VannucchiSeminars in Thrombosis and Hemostasis|May 2, 2013
JAK2 mutation-related disease and thrombosisAlessandro M Vannucchi, Paola GuglielmelliHematology. American Society of Hematology. Education Program|November 21, 2007
Thrombocytosis and thrombosisAlessandro M Vannucchi, Tiziano BarbuiPageof 33